-
-
-
-
-
-
-
Mirum Pharmaceuticals (MIRM) Provides Development Program Updates
-
-
-
-
-
-
-
Mirum Pharma (MIRM) Submits European MAA for Maralixibat in Alagille Syndrome Supported by New Positive Results from Natural History Study Comparison
-
8,117 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All